Abstract
This study developed a xeno-free (XF) spherical cell cluster of human adipose-derived stem cells (hASCs) for the treatment of severe ischemic diseases. hASCs are an attractive cell source for therapeutic angiogenesis. Herein, we describe an innovative method of culturing a three-dimensional cell mass (3DCM) in the XF condition and demonstrate the therapeutic potential and safety of XF-3DCMs in ischemic mice and in SCID/BALB/c Slc-nu/nu nude mice, respectively. XF-3DCMs were generated by culturing hASCs on a maltose-binding protein-linked basic fibroblast growth factor (bFGF)-immobilized polystyrene surface. XF-3DCMs produced comparable amounts of angiogenic factors such as bFGF, vascular endothelial growth factor, and interleukin-8 compared to 3DCMs formed in media containing FBS (fetal bovine serum)-3DCMs. The majority of the mice injected with XF-3DCMs exhibited limb salvaging and displayed similar blood perfusion compared to normal limbs. To a similar degree, as for FBS-3DCMs, XF-3DCMs enhanced therapeutic efficacy by increasing blood vessel regeneration, attenuating muscle degeneration and fibrosis, and facilitating the implantation of injected cells into host vessels. Furthermore, the soft agar colony-forming assay and in vivo tumorigenicity analysis showed that XF-3DCMs did not transform into tumor cells. No side effects were observed, including hematological and immunological toxicity, in mice injected with XF-3DCMs. These results suggest that XF-3DCMs show angiogenic and therapeutic efficacy in critical limb ischemia in mice and eliminate the safety problem of animal-derived material contamination, which is a prerequisite for clinical applications.
Impact Statement
We describe an innovative method of culturing a three-dimensional cell mass (3DCM) of human adipose-derived stem cells (hASCs) in the xeno-free (XF) condition for the treatment of severe ischemic diseases. The majority of the mice injected with XF-3DCMs exhibited limb salvaging and displayed similar blood perfusion compared to normal limbs. In vivo tumorigenicity and toxicity analysis showed that XF-3DCMs did not transform into tumor cells and induce toxicity, respectively. Our results strongly suggest that XF-3DCMs can be effectively used for therapeutic applications and eliminate immunological reaction of animal-derived material contamination.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
